Browse

Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia

DC Field Value Language
dc.contributor.authorYoon, Y. S.-
dc.contributor.authorLee, H. J.-
dc.contributor.authorYoon, H. I.-
dc.contributor.authorYoo, C-G-
dc.contributor.authorKim, Y. W.-
dc.contributor.authorHan, S. K.-
dc.contributor.authorSHIM, Y-S.-
dc.contributor.authorYIM, Jae-Joon-
dc.date.accessioned2009-09-29T12:20:01Z-
dc.date.available2009-09-29T12:20:01Z-
dc.date.issued2005-11-
dc.identifier.citationInt J Tuberc Lung Dis 2005; 9: 1215-1219en
dc.identifier.issn1027-3719 (print)-
dc.identifier.issn1815-7920 (online)-
dc.identifier.urihttp://www.ingentaconnect.com/content/iuatld/ijtld/2005/00000009/00000011/art00007-
dc.identifier.urihttps://hdl.handle.net/10371/9986-
dc.description.abstractOBJECTIVE: The excellent in vitro activity of fluoroquinolones against Mycobacterium tuberculosis has raised concerns about the delayed diagnosis of pulmonary tuberculosis (PTB) initially misdiagnosed as pneumonia. The aim of this study was to assess the effect of empiric fluoroquinolone therapy on delays in diagnosis in patients with PTB initially misdiagnosed as bacterial pneumonia.

DESIGN: Patients with PTB initially treated as having community-acquired pneumonia and treated with fluoroquinolones for more than 5 consecutive days, from January 2000 to December 2004, were enrolled. As a control group, TB patients initially treated with non-fluoroquinolone antibiotics were enrolled. We reviewed the clinical data and compared treatment responses between the two groups.

RESULTS: Nine patients in the fluoroquinolone group and 19 patients in the non-fluoroquinolone group were enrolled. In the fluoroquinolone group, eight patients (89%) improved clinically or radiographically, whereas only eight patients (42%) in the non-fluoroquinolone group improved (P = 0.04). The delay in initiation of anti-tuberculosis medication was longer in the fluoroquinolone group than in the non-fluoroquinolone group (43.1 ± 40.0 vs. 18.7 ± 16.9 days, P = 0.04).

CONCLUSION: Delay in the initiation of anti-tuberculosis treatment is possible in patients administered fluoroquinolone and initially misdiagnosed as having bacterial pneumonia.
en
dc.language.isoenen
dc.publisherInternational Union Against Tuberculosis and Lung Diseaseen
dc.subjecttuberculosisen
dc.subjectfluoroquinoloneen
dc.subjectdiagnosisen
dc.titleImpact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumoniaen
dc.typeArticleen
dc.contributor.AlternativeAuthor임재준-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Radiology (영상의학전공)Journal Papers (저널논문_영상의학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse